These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 20091489
1. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry. Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y. J Nephrol; 2010; 23(1):70-6. PubMed ID: 20091489 [Abstract] [Full Text] [Related]
2. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy. Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D. J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671 [Abstract] [Full Text] [Related]
3. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K. Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713 [Abstract] [Full Text] [Related]
4. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S. Nephrol Dial Transplant; 2008 Jun 29; 23(6):1931-9. PubMed ID: 18178603 [Abstract] [Full Text] [Related]
5. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y. J Am Soc Nephrol; 1998 Apr 29; 9(4):577-82. PubMed ID: 9555659 [Abstract] [Full Text] [Related]
6. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K. Kidney Int; 2001 Mar 29; 59(3):1077-85. PubMed ID: 11231363 [Abstract] [Full Text] [Related]
7. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing. Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M. J Proteomics; 2013 Oct 30; 92():299-312. PubMed ID: 23891555 [Abstract] [Full Text] [Related]
8. IgA-containing immune complexes in the urine of IgA nephropathy patients. Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J. Nephrol Dial Transplant; 2006 Sep 30; 21(9):2478-84. PubMed ID: 16757497 [Abstract] [Full Text] [Related]
9. O-glycosylation of serum IgD in IgA nephropathy. Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J. J Am Soc Nephrol; 2006 Apr 30; 17(4):1192-9. PubMed ID: 16510764 [Abstract] [Full Text] [Related]
10. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. Smith AC, Molyneux K, Feehally J, Barratt J. J Am Soc Nephrol; 2006 Dec 30; 17(12):3520-8. PubMed ID: 17093066 [Abstract] [Full Text] [Related]
11. Structural features of IgA molecules which contribute to IgA nephropathy. Feehally J, Allen AC. J Nephrol; 1999 Dec 30; 12(2):59-65. PubMed ID: 10378660 [Abstract] [Full Text] [Related]
12. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function. Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M. J Am Soc Nephrol; 2021 Oct 30; 32(10):2455-2465. PubMed ID: 34127537 [Abstract] [Full Text] [Related]
13. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin. Linossier MT, Palle S, Berthoux F. Am J Kidney Dis; 2003 Mar 30; 41(3):558-64. PubMed ID: 12612978 [Abstract] [Full Text] [Related]
14. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy. Iwatani H, Inoue T, Wada Y, Nagasawa Y, Yamamoto R, Iijima H, Takehara T, Imai E, Rakugi H, Isaka Y. Biochem Biophys Res Commun; 2012 Nov 23; 428(3):339-42. PubMed ID: 23098908 [Abstract] [Full Text] [Related]
15. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy. Allen AC. J Nephrol; 1999 Nov 23; 12(2):76-84. PubMed ID: 10378662 [Abstract] [Full Text] [Related]
16. Comprehensive analysis of short peptides in sera from patients with IgA nephropathy. Kaneshiro N, Xiang Y, Nagai K, Kurokawa MS, Okamoto K, Arito M, Masuko K, Yudoh K, Yasuda T, Suematsu N, Kimura K, Kato T. Rapid Commun Mass Spectrom; 2009 Dec 23; 23(23):3720-8. PubMed ID: 19902551 [Abstract] [Full Text] [Related]
17. Exposed peptide core of IgA1 hinge region in IgA nephropathy. Kokubo T, Hiki Y, Iwase H, Tanaka A, Nishikido J, Hotta K, Kobayashi Y. Nephrol Dial Transplant; 1999 Jan 23; 14(1):81-5. PubMed ID: 10052482 [Abstract] [Full Text] [Related]
18. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Ding JX, Xu LX, Lv JC, Zhao MH, Zhang H, Wang HY. Clin Immunol; 2007 Dec 23; 125(3):268-74. PubMed ID: 17913589 [Abstract] [Full Text] [Related]
19. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y. Nephrol Dial Transplant; 2000 Jan 23; 15(1):28-33. PubMed ID: 10607764 [Abstract] [Full Text] [Related]
20. Structural analyses of O-glycan sugar chains on IgA1 hinge region using SELDI-TOFMS with various lectins. Takahashi K, Hiki Y, Odani H, Shimozato S, Iwase H, Sugiyama S, Usuda N. Biochem Biophys Res Commun; 2006 Nov 24; 350(3):580-7. PubMed ID: 17022936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]